Viking Holdings Ltd (VIK) stock saw a modest uptick, ending the day at $43.05 which represents a slight increase of $0.44 or 1.03% from the prior close of $42.61. The stock opened at $42.46 and ...

Michael Salfino lays out his reasoning for who the Minnesota Vikings should choose as their QB of the future and who they ...

With so much on the line in Sunday’s game at Ford Field, the Vikings got creative ahead of their matchup with the Lions. In ...

Viking Therapeutics Inc’s profitability metrics reveal strong financial health. The company currently boasts a gross margin of -16.62%. The profit margin, also known as the revenue ratio or gross ...

JPMorgan keeps an Overweight rating and $80 price target on Viking Therapeutics (VKTX) after the company announced that it has initiated the ...

The Pittsburgh Steelers could very well be looking for a Donte Jackson replacement in free agency in 2025 and one NFL analyst ...

EAGAN, Minn. (AP) — As the Minnesota Vikings were recently reveling in their 14th victory, a two-point triumph over rival Green Bay that only became secure when Cam Akers made a tricky third down ...

JPMorgan highlights valuation resets for Viking and Structure Therapeutics, citing opportunities in T2D/obesity and competitive clinical data insights.

The Minnesota Vikings dodged the mess that former starting quarterback Kirk Cousins is now navigating with the Atlanta Falco.

Viking Therapeutics, Inc. (VKTX) closed the latest trading day at $42.68, indicating a +0.78% change from the previous session's end. This move outpaced the S&P 500's daily loss of 0.04%.